143 related articles for article (PubMed ID: 25473651)
21. Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study.
Westergaard RP; Hochstatter KR; Andrews PN; Kahn D; Schumann CL; Winzenried AE; Sethi AK; Gangnon RE; Sosman JM
AIDS Behav; 2019 Sep; 23(9):2549-2557. PubMed ID: 30790170
[TBL] [Abstract][Full Text] [Related]
22. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
[TBL] [Abstract][Full Text] [Related]
23. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Incarceration: Characterizing Jail Incarceration for Public Health Research.
Camplain R; Warren M; Baldwin JA; Camplain C; Fofanov VY; Trotter RT
Epidemiology; 2019 Jul; 30(4):561-568. PubMed ID: 30985527
[TBL] [Abstract][Full Text] [Related]
25. Highly active antiretroviral therapy use and HIV transmission risk behaviors among individuals who are HIV infected and were recently released from jail.
Clements-Nolle K; Marx R; Pendo M; Loughran E; Estes M; Katz M
Am J Public Health; 2008 Apr; 98(4):661-6. PubMed ID: 18309132
[TBL] [Abstract][Full Text] [Related]
26. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and Predictors of Reincarceration after Correctional Center Release: A Population-based Comparison of Individuals with and without Schizophrenia in Ontario, Canada: Prévalence et prédicteurs de la réincarcération après la libération d'un centre correctionnel : une comparaison dans la population-de personnes souffrant ou non de schizophrénie en Ontario, Canada.
Mahentharan M; Kouyoumdjian FG; de Oliveira C; Iwajomo T; Simpson AIF; Jones R; Kurdyak P
Can J Psychiatry; 2021 Apr; 66(4):376-384. PubMed ID: 32856464
[TBL] [Abstract][Full Text] [Related]
28. Association between contact with mental health and substance use services and reincarceration after release from prison.
Thomas EG; Spittal MJ; Taxman FS; Puljević C; Heffernan EB; Kinner SA
PLoS One; 2022; 17(9):e0272870. PubMed ID: 36070251
[TBL] [Abstract][Full Text] [Related]
29. PREDICTING RECIDIVISM FOR RELEASED STATE PRISON OFFENDERS: Examining the Influence of Individual and Neighborhood Characteristics and Spatial Contagion on the Likelihood of Reincarceration.
Stahler GJ; Mennis J; Belenko S; Welsh WN; Hiller ML; Zajac G
Crim Justice Behav; 2013 Jun; 40(6):690-711. PubMed ID: 24443612
[TBL] [Abstract][Full Text] [Related]
30. Emergency health service contact and reincarceration after release from prison: A prospective cohort study.
de Andrade DF; Spittal MJ; Snow KJ; Taxman FS; Crilly JL; Kinner SA
Crim Behav Ment Health; 2019 Apr; 29(2):85-93. PubMed ID: 30697841
[TBL] [Abstract][Full Text] [Related]
31. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
[TBL] [Abstract][Full Text] [Related]
32. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
33. [HIV risk behavior in prison and factors associated with reincarceration of injection drug users].
Rotily M; Delorme C; Galinier A; Escaffre N; Moatti JP
Presse Med; 2000 Sep; 29(28):1549-56. PubMed ID: 11072370
[TBL] [Abstract][Full Text] [Related]
34. Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.
Tinago W; O'Halloran JA; O'Halloran RM; Macken A; Lambert JS; Sheehan GJ; Mallon PW
HIV Med; 2014 Apr; 15(4):224-32. PubMed ID: 24215370
[TBL] [Abstract][Full Text] [Related]
35. Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release.
Booker CA; Flygare CT; Solomon L; Ball SW; Pustell MR; Bazerman LB; Simon-Levine D; Teixeira PA; Cruzado-Quinones J; Kling RN; Frew PM; Spaulding AC;
AIDS Behav; 2013 Oct; 17 Suppl 2():S128-36. PubMed ID: 23224290
[TBL] [Abstract][Full Text] [Related]
36. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P
HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618
[TBL] [Abstract][Full Text] [Related]
37. Predictors of reincarceration among patients who received psychiatric services in jail.
Draine J; Solomon P; Meyerson A
Hosp Community Psychiatry; 1994 Feb; 45(2):163-7. PubMed ID: 8168798
[TBL] [Abstract][Full Text] [Related]
38. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
Jaspan HB; Berrisford AE; Boulle AM
Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
[TBL] [Abstract][Full Text] [Related]
39. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.
Reitz C; Coovadia A; Ko S; Meyers T; Strehlau R; Sherman G; Kuhn L; Abrams EJ
J Infect Dis; 2010 Apr; 201(8):1121-31. PubMed ID: 20214476
[TBL] [Abstract][Full Text] [Related]
40. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
